This year’s forums were hybrid, allowing for greater global exposure, while allowing us to meet in-person.

Follow us on our social channels for the latest updates.

 


The Retina Forum 2023 was on
Wednesday 04 October 2023
and held at the
Hyatt Regency Hotel, Amsterdam

 

The Ophthalmology Futures Retina Forum 2023 covered several key topics, including the use of dual mechanism anti-VEGF therapies, the role of AI and digital health, gene therapy for retinal diseases, sustained delivery for anti-VEGF therapy, and novel therapies for geographic atrophy. The Forum also explored the impact of global regulatory processes on retinal disease and therapy.

The discussions and insights generated from the forum have the potential to shape the future of retinal disease management.

>> Click here to download the PDF programme


 

09:30 - 10:20

Registration

10:20 - 10:30
10:30 - 11:00

Panel 1: Dual Mechanism Anti-VEGF Therapies vs Novel Formulations of Older Agents: Will Patients & Providers have a Preference?

Co-chairs

Francesco Bandello
Robyn Guymer

Panellists

Gemmy Cheung
Grégoire Schwach
Nancy Holecamp
Stephen Poor
Surendra Sharma

11:00 - 11:30

Panel 2: Can AI & Digital Health Accelerate the Execution or Reduce the Cost of Clinical Trials?

Co-chairs

Adnan Tufail
Ursula Schmidt-Erfurth

Panellists

Andrzej Grzybowski
Cynthia Toth
Dawn Sim
Kester Nahen
Stephane Wolf
Stephanie Magazzeni

11:30 - 12:00

Networking Break

12:00 - 12:30

Panel 3: Novel Instrumentation for Back of the Eye Diseases: Who Will Continue to Invest?

Chair

Paulo Stanga

Panellists

Eugene de Juan
Karlheinz Rein
Lionel Jouet
Marc de Smet
Paul Hallen

12:30 - 13:00

Panel 4: Visual Preservation in Retinal Diseases: Will Gene Therapy Make a Dent?

Chair

Dominik Fischer

Panellists

Andreas Clemens
Francine Behar-Cohen
Nadia Waheed
Ramin Valian
Robert Kim
Samarendra Mohanty
Victor Chong

13:00 - 13:50

Networking Lunch

Sponsored by

13:50 - 15:20

Company Presentations 1

  • Notal Vision
    Kester Nahen  |  CEO
  • Eyecheckup
    Rim Khazhin  |  CTO
  • Deepeye Medical
    Ratko Petrovic  |  CTO
  • Photoprotective Technology
    James Gallas  |  Director, New Business Development
  • Endogena Therapeutics
    Matthias Steger  |  CEO
  • Beacon Therapeutics
    Darin Curtiss  |  VP of Clinical Development
  • Nanoscope Therapeutics
    Samarendra Mohanty  |  President & CSO
  • AAVantegarde Bio
    Natalia Misciattelli  |  Head of Corp Development
  • Eyevensys
    Francine Behar Cohen  |  CEO & President
  • REGENXBIO
    Sumie Takahara  |  Director, Global Product & Market Planning
15:20 - 15:30

Investment Perspective

Nanna Lüneborg

15:30 - 16:00

Panel 5: Investment in Back of the Eye Products: Is it Safer than Buying Cryptocurrency?

Chair

Nanna Lüneborg

Panellists

Christina Takke
Daniela Couto
Elisa Petris
Klaus Stöekemann
Limin Wang
Rusty Kelley

16:00 - 16:30

Panel 6: Sustained Delivery for Anti-VEGF Therapy: Come & Gone, or Still in Play?

Chair

Eugene de Juan

Panellists

Christopher Brittain
Jason Ehrlich
Melissa Liew
Michael O’Rourke
Michael Singer
Riad Sherif

16:30 - 16:50

Networking Break

16:50 - 18:30

Company Presentations 2

  • Re-Vana Therapeutics
    Michael O’Rourke  |  CEO
  • Tarsier Pharma
    Daphne Haim Langford  |  CEO
  • Oculis 
    Riad Sherif  |  CEO
  • Aldropika Therapeutics
    Uttam Surana  |  CSO
  • Ocuterra Therapeutics
    Kerrie Brady  |  CEO & President
  • Outlook Therapeutics
    Surendra Sharma  |  SVP-Medical Affairs
  • Kuria Therapeutics
    Keith Ward  |  CEO
  • Complement Therapeutics
    Rafiq Hasan  |  CEO
  • Aviceda Therapeutics
    Tarek Hassan  |  Chief Development Office
  • Apellis Pharmaceuticals
    Lukas Scheibler  |  Chief Research Officer
  • Iveric Bio, An Astellas Company
    Erin Henry  |  VP, Product, Strategy & Innovation
18:30 - 19:00

Panel 7: Global Harmonization of Regulatory Processes for Drugs & Biologics: The Impact on Retinal Disease & Therapy

Chair

Kuldev Singh

Panellists

Art Ciociola
Maryam Mokhtarzadeh
Sally Tucker

19:00 - 19:30

Panel 8: Novel Therapies for Geographic Atrophy: How do we Measure Success for Physicians, Patients & Payers?

Co-chairs

Usha Chakravarthy
Einar Stefánsson

Panellists

Art Ciociola
Caroline Baumal
Erin Henry
Mohamed Genead
Rafiq Hasan
Sobha Sivaprasad

19:30 - 19:40

Summary

19:40 - 19:45

Concluding Comments

Kuldev Singh
Keith Barton

19:45 - 21:00

Reception

 

 


Our Ophthalmology Futures Forums are clinician-driven innovation meetings focusing on new technology, entrepreneurial ventures, market access, and other aspects of commercialisation in the ophthalmic healthcare sector.

They cover all aspects of global innovation in ophthalmic devices, diagnostics, and pharmaceuticals by connecting scientists, physicians, regulators, reimbursement specialists, corporate leaders, venture capitalists, and other investors who support the advancement of eye care.

 


Sponsorship Opportunities

Our forum sponsorship opportunities offer organisations of all sizes a unique platform to promote their organisation, products, and services to prominent business and scientific leaders.

If your organisation would be interested in presenting at one of our Forums, please submit your application via the Apply to Present page.

Sponsorship opportunities are available for our European, Asian and Retina Forums or special rates are available for combined sponsorship. Please contact us for further information or for a sponsorship prospectus.